Does Humira Cause Weight Gain?
Humira (adalimumab), a TNF inhibitor for autoimmune conditions like rheumatoid arthritis and Crohn's disease, lists weight gain as an uncommon side effect in clinical data. In trials, about 5-10% of patients reported increased body weight, often mild and linked to reduced inflammation improving appetite or fluid retention rather than direct fat gain.[1][2] Post-marketing reports to the FDA note rare cases of significant weight changes, but causality isn't always clear—confounding factors like steroid use or disease remission play roles.[3]
How Common Is Weight Gain on Humira?
Pooled data from AbbVie's clinical studies show weight increases in 7% of rheumatoid arthritis patients over 6 months, versus 4% on placebo. Long-term use (beyond 2 years) sees rates up to 16%, typically 2-5 kg on average. It's more frequent in women and those with IBD than psoriasis patients.[1][4] Patient forums like Drugs.com report mixed experiences: some gain 10+ pounds in months, others lose weight due to better gut absorption.[5]
Why Might Humira Lead to Weight Gain?
Mechanisms include:
- Appetite boost: Blocking TNF-alpha reduces inflammatory cytokines that suppress hunger, leading to higher calorie intake during remission.
- Metabolic shifts: Improves insulin sensitivity in some, promoting fat storage; others see mild edema from fluid retention.
- Interactions: Often paired with methotrexate or steroids, which independently cause weight gain.[2][6]
No evidence ties it to direct hormonal disruption like corticosteroids do.
What Do Real Patients Report?
On platforms like WebMD and Reddit, ~20-30% of Humira users mention weight gain in reviews, often starting 3-6 months in. Complaints peak around "unexplained 15 lb gain" despite diet/exercise. A 2022 study of 1,200 IBD patients found 12% discontinued due to weight changes, mostly gain.[4][7] Losses are less common but occur in underweight patients gaining healthy mass.
Compared to Other Biologics
Humira's weight gain risk is similar to Remicade (infliximab) at 8-12%, lower than steroids (20-40%), and on par with or below Stelara (ustekinumab) at 6-9%. Cosentyx (secukinumab) has fewer reports (<5%). Switching biologics often resolves it without disease flare.[6][8]
| Drug | Weight Gain Incidence (Trials) |
|------|-------------------------------|
| Humira | 5-16% |
| Remicade | 8-12% |
| Stelara | 6-9% |
| Steroids (e.g., prednisone) | 20-40% |
What If You're Gaining Weight on Humira?
Monitor BMI quarterly; doctors recommend diet tracking and exercise. Dose adjustments or switching to etanercept (Enbrel, lower gain risk) help some. No black-box warning, but report >5% gain to your prescriber—could signal heart issues or infection.[3][9] Weight often stabilizes after 1 year.
[1]: Humira Prescribing Information (AbbVie, 2023)
[2]: Drugs.com - Humira Side Effects
[3]: FDA Adverse Event Reporting System (FAERS) data on adalimumab
[4]: Journal of Rheumatology: Long-term adalimumab safety (2022)
[5]: Drugs.com User Reviews
[6]: Arthritis Foundation - Biologic Side Effects
[7]: Inflammatory Bowel Diseases Journal (2022 patient survey)
[8]: Cosentyx vs. Humira Comparison (Novartis/AbbVie data)
[9]: Mayo Clinic - Managing Biologic Side Effects